期刊文献+

尼群地平胶囊自乳化释药系统处方优化研究 被引量:13

Studies on Optimizing the Formula of Nitrendipine Self-emulsifying Drug Delivery System
下载PDF
导出
摘要 目的 :优化尼群地平自乳化释药系统处方。方法 :以尼群地平在不同种类及比例的油相、表面活性剂中的溶解度为考察指标 ,筛选尼群地平自乳化释药系统处方。结果 :尼群地平自乳化释药系统处方为尼群地平、肉豆寇酸异丙酯、Labrasol、Tween 80、十二烷基硫酸钠 ,该处方所形成的微乳平均粒径为 11 1nm ,在溶出介质蒸馏水、0 1mol/LHCl、pH 6 8磷酸盐缓冲液中的溶出度无明显差异 ,4 5min时的溶出度均在 75 %以上。结论 :按优化处方制得的尼群地平自乳化释药系统大大提高了尼群地平在水中的溶出度。 AIM:To optimize the formula of nitrendipine self-emulsifying drug delivery system.METHOD:Screening the formula of nitrendipine self-emulsifying drug delivery system on the basis of the solubility of nitrendipine in various kinds and ratios of surfactants and oil phases.RESULT: The formula of nitrendipine self-emulsifying drug delivery system was composed of Nitrendipine/IPM/Labrasol/Tween-80/SLS.It can create microemulsion droplets with a mean droplet size of 11.1 nm.The dissolution has no significant difference in distilled water,0.1 mol/L hydrochloric acid and phosphorate buffer,which was over 75% at 45 min.CONCLUSION:The dissolution of nitrendipine in water was significantly increased by using optimized formula of nitrendipine self-emulsifying drug delivery system.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2004年第3期211-214,共4页 Journal of China Pharmaceutical University
关键词 尼群地平 自乳化 释药系统 溶出度 Nitrendipine Self-emulsifying drug delivery system Dissolution
  • 相关文献

参考文献5

二级参考文献14

  • 1Tarr B D, Yalkowsky S H. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size[J]. Pharm Res, 1989,6(1): 40-43.
  • 2Charman S A,Charman W N,Rogge M C,et al. Self-emulsifying drug delivery systems:formulation and biopharmaceutic evaluation of an investigatinal lipophilic compound[J].Pharm Res,1992,9(1) :87-93.
  • 3Constantinides P p. Lipid microemulsions for improving drug dissolution and oral absorption:physical and biopharmaceutical aspects[J]. Pharm Res, 1995,12(11): 1561-1572.
  • 4Hauss D J,Fogal S E,Ficorilli J V,et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor[J]. J Pharm Sci, 1998,87(2) : 164-169.
  • 5Pouton C W. Formulation of self-emulsifying drug delivery systems[J]. Advanced Drug Delivery Reviews, 1997,25(4):47-58.
  • 6Craig D Q M,Lievens H S R,Pitt K G, et al. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis [J]. Int J Pham, 1993,96(7) : 147-155.
  • 7Pouton C W. Effects of the inclusion of a model drug on the performance of self emulsifying formulation [J]. J Pharm Phamacol, 1985,37 (1) : 1-11.
  • 8Florence A T. The oral absorption of micro- and nano-particulates: neither exceptional nor unusual[J]. Pharm Res, 1997,14 (3): 259-266.
  • 9Serajuddin A T M. Sheen P C,Mufson D,et al. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersion[J]. J Pharm Sci, 1988,77(5) : 414-417.
  • 10Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone[J]. Pharm Dev Technol, 1996,1 (2): 147-157.

共引文献81

同被引文献188

引证文献13

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部